Tag: Human Papillomavirus (HPV)
Coverage With HPV Vaccine Continuing to Increase in Boys
Teens whose parents received a provider recommendation had higher coverage with HPV vaccine
ACIP Recommends Catch-Up HPV Vaccines Through Age 26
For adults aged 27 to 45 years, vaccination may be beneficial for some who are inadequately vaccinated
One Dose of HPV Vaccine May Be Sufficient in Certain Situations
One dose compared with two or three doses in preventing cervical precancer in high-coverage settings
Targeted Interventions Raise HPV Vaccine Acceptance in Women
Educational videos produced the highest rate of acceptability and knowledge
Review: HPV Vaccination Program Has Considerable Impact
Prevalence of HPV 16 and 18 decreased; anogenital wart diagnoses down in girls, women, boys, men
ACIP: Men as Old as 26 Should Get HPV Vaccine
Panel also no longer advises that healthy Americans ≥65 routinely receive Prevnar 13 vaccination
HPV16 Antibodies Can Develop Long Before Throat Cancer Diagnosis
HPV16-E6 seropositivity increases with shorter lead time, reaching 38.9 percent for <10 years
Mouth Rinse for HPV DNA May Be Biomarker in Head, Neck Cancer
Persistent detection of tumor-type HPV DNA during treatment tied to increased risk for recurrence, death
CDC: Recent Decline Seen in High-Grade Cervical Lesions
Vast majority of cervical precancer cases attributable to HPV types targeted by 9-valent HPV vaccine
Histologic Clearance of CIN2/3 Seen With HPV Therapeutic Vaccine
In phase II trial, rate of complete resolution of CIN2/3 significantly higher for vaccine versus placebo group
